Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Lobular × Indocyanine Green × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Neoplasms 7 Lung Neoplasms 5 Endometrial Neoplasms 5 Melanoma 4 Head and Neck Neoplasms 4 Esophageal Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Solitary Pulmonary Nodule 2 Multiple Pulmonary Nodules 2 Lymphedema 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Vulvar Neoplasms 1 Uterine Neoplasms 1 Thyroid Neoplasms 1 Suspected Central Nervous System Tumors 1 Stomach Neoplasms 1 Skull Base Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pediatric Patients With Solid Tumors 1 Ovarian Neoplasms 1

Interventions

Radiotherapy 3 Chemotherapy, Adjuvant 3 Magnetic Resonance Spectroscopy 2 Letrozole 2 Carboplatin 2 gallium 68 PSMA-11 1 fluciclovine F-18 1 atamestane 1 Zolpidem 1 Venlafaxine Hydrochloride 1 Trastuzumab 1 Toremifene 1 Thiotepa 1 Tamoxifen 1 Reverse Transcriptase Polymerase Chain Reaction 1 Radiotherapy, Conformal 1 Radiation 1 Proton Therapy 1 Paclitaxel 1 Melphalan 1 Mass Spectrometry 1 Indocyanine Green 1 Immunohistochemistry 1 Histocompatibility Testing 1 Gene Expression Profiling 1 Fluorescent Antibody Technique 1 Estrogen Receptor Modulators 1 Docetaxel 1 Cyclophosphamide 1 Counseling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01796041 2021-01-28

ICG

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Carcinoma, Lobular, Carcinoma, Ductal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡